Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation

被引:0
|
作者
Marx, S.
Diener, H. -C. [2 ]
Harenberg, J.
Lip, G. [3 ]
Marder, V. [4 ]
Wehling, M.
Weiss, C. [1 ]
机构
[1] Univ Heidelberg, Med Fac Mannheim, Dept Biometr & Stat, D-6800 Mannheim, Germany
[2] Univ Clin Essen, Dept Neurol, Essen, Germany
[3] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:815 / 815
页数:1
相关论文
共 50 条
  • [41] Medication persistence and discontinuation of rivaroxaban and dabigatran etexilate among patients with non-valvular atrial fibrillation
    Nelson, Winnie W.
    Song, Xue
    Thomson, Erin
    Smith, David M.
    Coleman, Craig I.
    Damaraju, C. V.
    Schein, Jeffrey R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (10) : 1831 - 1840
  • [42] 2 Point Plasma Dabigatran, Rivaroxaban and Apixaban Levels in Patientswith Non-Valvular Atrial Fibrillation: A Single Centre Study
    Lim, M. S. H.
    Tiong, L. L.
    Tan, S. S. N.
    Ku, M. Y.
    Charles, S.
    Ong, T. K.
    Fong, A. Y. Y.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 249 : S26 - S27
  • [43] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Norby, Faye L.
    Bengtson, Lindsay G. S.
    Lutsey, Pamela L.
    Chen, Lin Y.
    MacLehose, Richard F.
    Chamberlain, Alanna M.
    Rapson, Ian
    Alonso, Alvaro
    BMC CARDIOVASCULAR DISORDERS, 2017, 17
  • [44] A meta-analysis of efficacy and safety of Watchman device for left atrial appendage closure in non-valvular atrial fibrillation
    Jhand, A.
    Thandra, A.
    Apala, D.
    Aggarwal, S.
    Saadi, A.
    Sayles, H.
    Goldsweig, A.
    Alla, V.
    EUROPEAN HEART JOURNAL, 2018, 39 : 818 - 818
  • [45] Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
    Faye L. Norby
    Lindsay G.S. Bengtson
    Pamela L. Lutsey
    Lin Y. Chen
    Richard F. MacLehose
    Alanna M. Chamberlain
    Ian Rapson
    Alvaro Alonso
    BMC Cardiovascular Disorders, 17
  • [46] COST - EFFECTIVENESS OF APIXABAN WITH OTHER NOACS (DABIGATRAN AND RIVAROXABAN) IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION (FANV) IN PATIENTS OF SOCIAL SECURITY OF PERU
    Sanabria, C.
    Cabrejos, J.
    Olortegui, A.
    Guevara, C.
    Garrido Lecca, S.
    VALUE IN HEALTH, 2015, 18 (07) : A829 - A829
  • [47] Differences in the characteristics of patients with non-valvular atrial fibrillation who are newly prescribed apixaban, rivaroxaban, dabigatran and VKA in general practice in the UK
    Ridha, E.
    Johnson, M.
    Lacoin, L.
    Collings, S. L.
    Parsons, V.
    Kloss, S.
    Stynes, G.
    Maguire, A.
    Lefevre, C.
    EUROPEAN HEART JOURNAL, 2016, 37 : 493 - 493
  • [48] Efficacy and safety of novel anticoagulant dabigatran in clinical practice for Japanese patients with non-valvular atrial fibrillation
    Miyamoto, Koji
    Aiba, Takeshi
    Nakajima, Ikutaro
    Yamada, Yuko
    Okamura, Hideo
    Noda, Takashi
    Satomi, Kazuhiro
    Ishihara, Masaharu
    Anzai, Toshihisa
    Yasuda, Satoshi
    Ogawa, Hisao
    Kamakura, Shiro
    Shimizu, Wataru
    JOURNAL OF ARRHYTHMIA, 2014, 30 (01) : 58 - 64
  • [49] Risk of major bleeding among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban, or warfarin in the US Medicare population
    Amin, A.
    Keshishian, A.
    Trocio, J.
    Dina, O.
    Le, H.
    Rosenblatt, L.
    Mardekian, J.
    Zhang, Q.
    Baser, O.
    Liu, X.
    Vo, L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 964 - 964
  • [50] Comparison of dabigatran and warfarin used in patients with non-valvular atrial fibrillation Meta-analysis of random control trial
    Yu, Yi-bo
    Liu, Jing
    Fu, Guo-hua
    Fang, Ren-yuan
    Gao, Fang
    Chu, Hui-min
    MEDICINE, 2018, 97 (46)